(90 tablets)
Improved Appetite Regulation Physical activity influences appetite-regulating hormones, reducing cravings
However, an oral version of the drug (aka the Wegovy pill ) is awaiting FDA approval and may be given the green light soon
Most clinical guidance recommends: At 3 months: A1c recheck (HbA1c reflects the prior 3-month average, making this the earliest timepoint for meaningful assessment of glycemic response), metabolic panel if any GI side effects were significant At 6 months: Full panel repeat A1c, CMP, lipids, CBC to document treatment response comprehensively Annually: Full panel plus thyroid function, B12, and any additional markers relevant to your individual health picture If you experience severe or persistent gastrointestinal side effects, signs of dehydration, unusual fatigue, or any concerning symptoms, kidney function should be rechecked without waiting for a scheduled interval
The main way GLP-1 RAs cause weight loss is by helping you eat less
